XOMA Earns $9 Million Milestone as FDA Grants Accelerated Approval to[...]
Aquestive Therapeutics to Report First Quarter 2024 Financial Results[...]
05/13/2021 | Press release | Distributed by Public on 05/14/2021 09:59
Please select the service you want to use:
Smartlinks | Brickell Biotech Inc. | News | Education | Health | Science | Research | Local News | Business and Economy | Finance | Stock Markets | Security Markets | Stock Markets | Security Markets | Company News | Top Company News | Business Announcement | Products and Services | Corporate Litigation and Regulation | Pharmaceuticals | Lifestyle and Leisure | Leisure | Biotechnology and Medical Research Companies | Börse Frankfurt | Börse Berlin | Börse München | Börse Stuttgart | Tradegate Exchange | NYSE American | NYSE ARCA Equities | Nasdaq Capital Market | BZX Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | NYSE National | Nasdaq BX | Nasdaq PSX | FINRA Alternative Display Facility (ADF) | NYSE Chicago
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact